Clinical course after successful double lung transplantation in a patient with severe scoliosis

2011 ◽  
Vol 30 (2) ◽  
pp. 234-235 ◽  
Author(s):  
Puneet S. Garcha ◽  
Jose F. Santacruz ◽  
Michael S. Machuzak ◽  
Marie M. Budev ◽  
Atul Mehta
2019 ◽  
Vol 38 (4) ◽  
pp. S313
Author(s):  
H. Oda ◽  
T.F. Chen-Yoshikawa ◽  
Y. Yokoyama ◽  
M. Ikeda ◽  
J. Tokuno ◽  
...  

CHEST Journal ◽  
2008 ◽  
Vol 134 (4) ◽  
pp. 21C
Author(s):  
Jang Wen Su ◽  
David P. Mason ◽  
Sudish C. Murtthy ◽  
Gosta B. Pettersson ◽  
Marie Budev ◽  
...  

2012 ◽  
Vol 31 (4) ◽  
pp. S180-S181
Author(s):  
R. Walia ◽  
T.N. Hodges ◽  
J.L. Huang ◽  
K.A. Varsch ◽  
R. Saggar ◽  
...  

2013 ◽  
Vol 26 (3) ◽  
pp. 322-330 ◽  
Author(s):  
Martin Dierich ◽  
Andreas Tecklenburg ◽  
Thomas Fuehner ◽  
Uwe Tegtbur ◽  
Tobias Welte ◽  
...  

2018 ◽  
Vol 39 (02) ◽  
pp. 172-180
Author(s):  
Ramsey Hachem

AbstractOutcomes after lung transplantation remain disappointing because there is a high incidence of chronic lung allograft dysfunction (CLAD), which typically follows a progressive clinical course and often results in allograft failure and death. Chronic rejection is considered the predominant cause of CLAD. Thus, optimal immunosuppression has been viewed as having the potential to prevent CLAD and improve survival after lung transplantation. Numerous clinical trials have been conducted investigating the efficacy and safety of various immunosuppressive agents. Many studies have been small and single-center clinical trials but some have been international and multicenter trials enrolling more than 300 patients. This review focuses on clinical trials of immunosuppression conducted in lung transplantation and points out strengths and limitations of the various studies. Ultimately, the findings of these clinical trials explain the current state of practice in lung transplantation and identify gaps in knowledge that require additional study. Finally, there is an ongoing need for carefully designed and conducted clinical trials to improve clinical practice and outcomes after lung transplantation.


Author(s):  
Takeshi Shiraishi ◽  
Haruhisa Yanagida ◽  
Yuhki Koga ◽  
Shouichi Ohga ◽  
Masaki Fujita ◽  
...  

2008 ◽  
Vol 27 (11) ◽  
pp. 1262-1264 ◽  
Author(s):  
Jang Wen Su ◽  
David P. Mason ◽  
Sudish C. Murthy ◽  
Marie M. Budev ◽  
Atul C. Mehta ◽  
...  

2021 ◽  
Vol 8 ◽  
Author(s):  
Guohui Jiao ◽  
Xiangnan Li ◽  
Bo Wu ◽  
Hang Yang ◽  
Guoqing Zhang ◽  
...  

Background: Lung transplantation is recognized as the only therapeutic option for patients who develop irreversible pulmonary fibrosis after herbicide intoxication.Methods: We have collected and presented clinical course and outcome of four patients who received lung transplantation due to paraquat and diquat intoxication from 2018 to 2021. Another patient who received initial lung transplantation due to paraquat intoxication and re-transplantation due to chronic lung allograft dysfunction in 2019, was further reported. Patients were admitted in lung transplantation centers, including the 1st affiliated hospital of Zhengzhou University and Wuxi Lung transplantation center. Previous reported cases from Europe, Canada and China were also summarized as benchmark.Results: During the period from the year of 2018 to 2021, there have been four patients in China, who received lung transplantation due to herbicide intoxication. Median age of the four patients was 37 (IQR 34.5, 39.75) years old. Median time from intoxication to lung transplantation was 27.5 (IQR 27, 30.5) days. Bilateral lung transplantation was performed in three patients, while one single lung transplantation was performed in an urgent listed patient. Extracorporeal Membrane Oxygenation (ECMO) and hemopurification support were used in all patients (100%). Details of the cases with follow-ups were further presented and analyzed.Conclusions: Late timing of bilateral lung transplantation can be performed successfully for pulmonary fibrosis after paraquat or diquat intoxication. The survival of patients with complex perioperative conditions can be achieved with a multidisciplinary team to manage the irreversible effects of intoxication.


Sign in / Sign up

Export Citation Format

Share Document